Article Text

PDF
Decompressive hemicraniectomy in subarachnoid haemorrhage: the influence of infarction, haemorrhage and brain swelling
  1. E Güresir,
  2. A Raabe,
  3. M Setzer,
  4. H Vatter,
  5. R Gerlach,
  6. V Seifert,
  7. J Beck
  1. Department of Neurosurgery, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany
  1. Dr E Güresir, Department of Neurosurgery, Johann Wolfgang Goethe-University Frankfurt am Main, Schleusenweg 2–16, 60528 Frankfurt am Main, Germany; gueresir{at}em.uni-frankfurt.de

Abstract

Objective: To analyse decompressive hemicraniectomy (DHC) in patients with aneurysmal subarachnoid haemorrhage (SAH) with regard to infarction, haemorrhage or brain swelling.

Methods: DHC was performed in 43 of 787 patients with SAH. Patients were stratified according to (1) primary brain swelling without and (2) with additional intracerebral haematoma, (3) secondary brain swelling without rebleeding or infarcts and (4) with infarcts or (5) with rebleeding. Outcome was assessed according to the modified Rankin scale at 6 months

Results: Overall, 36 of 43 patients (83.7%) with DHC and 241 of 744 patients (32.4%) without DHC have been of a poor grade on admission (World Federation of Neurological Societies grading 4–5; p<0.0001). Favourable outcome was achieved in 11 of 43 (25.6%) patients with DHC. There was no difference in favourable outcome after primary (25%) versus secondary (26.1%) DHC (p = 1.0). Subgroup analysis (brain swelling vs bleeding vs infarcts) revealed no difference in the rate of favourable outcome. In a multivariate analysis, acute hydrocephalus (p = 0.02) and clinical herniation (p = 0.03) were significantly associated with unfavourable outcome.

Conclusions: We conclude that primary and secondary hemicraniectomy may be warranted, irrespective of the underlying aetiology—infarction, haemorrhage or brain swelling. The time from onset of intractable ICP to DHC seems to be crucial, rather than the time from SAH to DHC.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Ethics approval: Provided by Ethik-Kommission Goethe-Universität Frankfurt.

  • Patient consent: To be provided.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.